Ototoxicity and nephrotoxicity of amikacin: an overview of phase II and phase III experience in the United States.
D000328:Adult; D000368:Aged; D000583:Amikacin / Q000009:adverse effects*; D001299:Audiometry; D002648:Child; D003404:Creatinine / Q000097:blood; D004423:Ear / Q000187:drug effects; D006311:Hearing Disorders / Q000139:chemically induced*; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D007668:Kidney / Q000187:drug effects / Q000502:physiology; D007674:Kidney Diseases / Q000139:chemically induced*; D008875:Middle Aged; D014481:United States; D000159:Vestibulocochlear Nerve / Q000187:drug effects
D007612:Kanamycin; D000583:Amikacin; D003404:Creatinine